Niemann, B.; Moise, J.; Sestito, M.; Malla, M.; Train, K.; Murken, D.; Mayers, K.; Groves, E.; Garland-Kledzik, M.
Circulating Tumor DNA (ctDNA) Clearance May Predict Treatment Response in Neoadjuvant Colorectal Cancer Management. J. Clin. Med. 2024, 13, 1684.
https://doi.org/10.3390/jcm13061684
AMA Style
Niemann B, Moise J, Sestito M, Malla M, Train K, Murken D, Mayers K, Groves E, Garland-Kledzik M.
Circulating Tumor DNA (ctDNA) Clearance May Predict Treatment Response in Neoadjuvant Colorectal Cancer Management. Journal of Clinical Medicine. 2024; 13(6):1684.
https://doi.org/10.3390/jcm13061684
Chicago/Turabian Style
Niemann, Britney, John Moise, Michael Sestito, Midhun Malla, Kevin Train, Douglas Murken, Keri Mayers, Emily Groves, and Mary Garland-Kledzik.
2024. "Circulating Tumor DNA (ctDNA) Clearance May Predict Treatment Response in Neoadjuvant Colorectal Cancer Management" Journal of Clinical Medicine 13, no. 6: 1684.
https://doi.org/10.3390/jcm13061684
APA Style
Niemann, B., Moise, J., Sestito, M., Malla, M., Train, K., Murken, D., Mayers, K., Groves, E., & Garland-Kledzik, M.
(2024). Circulating Tumor DNA (ctDNA) Clearance May Predict Treatment Response in Neoadjuvant Colorectal Cancer Management. Journal of Clinical Medicine, 13(6), 1684.
https://doi.org/10.3390/jcm13061684
